You just read:

Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data for Xyrem® (sodium oxybate) in Pediatric Patients with Narcolepsy with Cataplexy

News provided by

Jazz Pharmaceuticals plc

03 Jun, 2018, 22:00 BST